Merck declares 1st-quarter dividend of 38 cents, says it will buy back up to $3B in stock ,reported by Chartpoppers.com

November 25, 2009

(EMAILWIRE.COM, November 25, 2009 ) Point Roberts, WA - Chartpoppers.com announces an investment report featuring company Merck & Co. (NYSE: MRK)

The Consolidated Investment Analysis on Merck & Co. (NYSE: MRK) will be in particular interest to other competing companys within in its sector, such as Pfizer Inc. (NYSE: PFE), Sanofi-Aventis SA (NYSE: SNY) and GlaxoSmithKline plc. (NYSE: GSK)

Merck & Co., Inc. (Merck) is a global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of products to improve human and animal health. The Company's operations are principally managed on a products basis and comprises of two business segments: the Pharmaceutical segment and the Vaccines and Infectious Diseases segment. The Pharmaceutical segment includes human health pharmaceutical products marketed either directly or through joint ventures.

Recent News on Merck & Co. (NYSE: MRK)

Drugmaker Merck & Co. declared a quarterly dividend of 38 cents on Tuesday, and said it plans to buy back as much as $3 billion in stock.
The dividend is payable Jan. 8, 2010, to shareholders of record Dec. 15. Merck also declared a preferred stock dividend of $3.75, payable Feb. 15 to shareholders of record on Feb. 1.
The company said its board approved the share buyback plan. It will purchase the stock on the open market or in privately negotiated transactions. It did not specify the length of the repurchase plan. Merck had 2.11 billion shares on the market as of Sept. 30.
In afternoon trading, Merck shares fell 23 cents to $36.19.

To view the Consolidated Investment Analysis on Merck & Co. (NYSE: MRK) Please visit the stock pulse page at http://www.chartpoppers.com/stock%20pulse/

In the report chartpoppers.com covers a recent financial Summary, Analyst Consensus, Technical Analysis, Comparative Analysis and Insider Trading Activity.

The full report is available at http://www.chartpoppers.com

Chartpoppers.com is a market research and investment commentary provider. Chartpoppers.com aims to bring undervalued, up and coming companies into the sight of both experienced and non-experienced investors. Our diligent effort is to help investors, at whatever stage in their careers, to get a grasp on the necessary financial data that they need in order to make a educated investment decision. From our daily trading ideas and penny picks to a in depth coverage of what's going on in the markets, we are sure that chartpoppers.com is exactly what you need in order succeed.

For More information please visit us at http://www.chartpoppers.com/about/

Chartpoppers.com Disclosure
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the "SEC") or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. ChartPoppers.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.


Chartpoppers.com
Paul Marek
6047245332
info@chartpoppers.com

Source: EmailWire.Com